Trending Now
Incyte Corporation (NASDAQ:INCY) Reports Positive Overall Response Rates (ORR) From the...
Incyte Corporation (NASDAQ:INCY) has exceptional know-how in medicinal chemistry and biology. The global company was founded under a strong motivation, which defined the need...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
XS Services at 3-Month High Following Non-Core Asset Sale
If you think all cannabis stocks are crumbling, you’re not seeing Xtraction Services (CSE:XS). Shares of the Los Angeles-based specialty finance company...
MAKE IT MODERN
LATEST REVIEWS
Advaxis Inc. (NASDAQ:ADXS) Provides Business Updates And Q2 2020 Financial Results
Advaxis Inc. (NASDAQ:ADXS) has reported its Q2 financial results for the quarter that ended April 30 and provided its clinical pipeline updates.
Promising Phase 1/2...
MAKE IT MODERN
PERFORMANCE TRAINING
PDS Biotechnology Corp. (NASDAQ:PDSB) Collaborator Receives an Award from NIAID to Fast-Track the Advancement...
Over the years, PDS Biotechnology Corp. (NASDAQ:PDSB) has engineered multiple therapies and continues to advance its pipeline of cancer immunotherapies and communicable disease vaccines....
Petroteq Energy Inc (OTCMKTS:PQEFF) Zeroes in on Eco-Friendly Oil Niche
We still don’t know for certain who will take home the prize in the election, but some things are certain. One big point that...
Vaccinex (NASDAQ:VCNX) Announce Pepinemab Study Results in HD And Enters clinical collaboration Deal With...
Vaccinex Inc. (NASDAQ:VCNX) has announced its second phase double-blind, placebo-controlled SIGNAL study of its experimental clinical treatment for Huntington's diseases, pepinemab, which did not...
Ardelyx Inc’s (NASDAQ: ARDX) Appeal to the Drug Advisory Committee Gets Temporarily Allowed
Ardelyx Inc (NASDAQ: ARDX) recently announced that certain health regulatory bodies such as the Centre for Disease Control and the Food and Drugs Authority...
Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In Nevada And Florida
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced that its wholly-owned subsidiary, Pasithea Clinics, has expanded the availability of IV ketamine therapy to Florida and...
MAKE IT MODERN
